PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis-Reference-Cited by-同舟云学术

PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis

Published:2015-07 Issue:1 Volume:63 Page:164-173
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Francque Sven,Verrijken An,Caron Sandrine,Prawitt Janne,Paumelle Réjane,Derudas Bruno,Lefebvre Philippe,Taskinen Marja-Riitta,Van Hul Wim,Mertens Ilse,Hubens Guy,Van Marck Eric,Michielsen Peter,Van Gaal Luc,Staels Bart

Publisher

Elsevier BV

Subject

Hepatology

Reference38 articles.

1. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults;Vernon;Aliment Pharmacol Ther,2011

2. From the metabolic syndrome to NAFLD or vice versa?;Vanni;Dig Liver Dis,2010

3. Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient – Death of a dogma from analysis of therapeutic studies?;Lonardo;Expert Rev Gastroenterol Hepatol,2011

4. Glitazones for human nonalcoholic steatohepatitis;Pais;Therap Adv Gastroenterol,2011

5. Hepato-protective effects of the dual PPARalpha/delta agonist GFT505 in rodent models of NAFLD/NASH;Staels;Hepatology,2013

Cited by 280 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weighted gene co-expression network analysis identified GBP2 connected to PPARα activity and liver cancer;Scientific Reports;2024-09-05

2. Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy;World Journal of Gastrointestinal Pathophysiology;2024-08-22

3. Development of Liver Fibrosis Represented by the Fibrosis-4 Index Is a Specific Risk Factor for Tubular Injury in Individuals with Type 2 Diabetes;Biomedicines;2024-08-07

4. Effect of Pemafibrate on the Lipid Profile, Liver Function, and Liver Fibrosis Among Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease;Gastroenterology Research;2024-08

5. Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver disease;npj Metabolic Health and Disease;2024-07-03